Company Information from ICIS

AstraZeneca is an international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services.

AstraZeneca will focus on strengthening its pipeline, driving top-line sales growth and making productivity improvements. A core priority for the company is to ensure that its growing range of candidate drugs (compounds with the potential to become new medicines) are developed effectively to meet the future needs of its patients.

However, the company will also continue to challenge all elements of its business to drive productivity and provide for the increased investment to support the achievement of its strategic objectives.

Download the The ICIS Top 100 Chemical Companies listing here

Key Personnel

Non-executive chairman: Louis Schweitzer
Chief executive officer: David Brennan
Chief financial officer: Simon Lowth
Non-executive director: Michele Hooper
Non-executive director: Bo Angelin


15 Stanhope Gate
London W1K 1LN

Tel: +44 020 7604 8000
Fax: +44 020 7304 5151


ICIS Top 100 Chemical Companies


The ICIS Top 100 Chemical Companies 2015 listing highlights the top players in the global chemical industry.

Most chemical companies found it difficult to generate top line and profit growth in 2015 following a strong performance in 2014. 

ICIS Top 100 Chemical Distributors 2015

ICIS Top 100 Chemical Distributors 2014

ICIS is proud to present the ICIS Top 100 Chemical Distributors. This feature, now in its fifth year is published annually in ICIS Chemical Business, the weekly magazine for the global chemical industry.